Close X
Monday, January 6, 2025
ADVT 
International

Reckless driver jailed for killing Sikh woman in UK

Darpan News Desk IANS, 12 Jan, 2023 10:51 AM
  • Reckless driver jailed for killing Sikh woman in UK

London, Jan 12 (IANS) A 23-year-old man in the UK has been jailed for six years for recklessly driving at a speed of nearly 100 mph, which led to the death of a Sikh woman -- mother to a five-month-old.

Hashim Aziz was driving at over three times the speed limit to "impress his cousins" when his Audi A3 crashed into Baljinder Kaur Moore's Vauxhall Corsa in West Midlands, in November last year, the Mirror reported.

Baljinder, 32, was on her way to pick up her husband from his brother's home, and she was driving at 62 mph.

The Wolverhampton Crown Court heard that two witnesses had spotted Aziz flying past them "in excess of 100mph" before they heard "loud bangs".

The severity of the impact caused one of the car engines "to become detached" while debris was left scattered 30 metres away, prosecutor Cathlyn Orchard said.

Baljinder was announced dead on the spot by paramedics.

According to the Mirror, Aziz, a resident of Highgate Drive, Walsall, initially tried to blame the victim for the tragedy during a police interview but later admitted causing death by dangerous driving.

"He accepts full responsibility for what was a catastrophic accident. He simply shouldn't have been travelling anywhere near that speed," Aziz's defence counsel, Adam Morgan, said.

During his sentencing at Wolverhampton Crown Court on Tuesday, Aziz expressed "full remorse" for the crash.

The court was told that Aziz had a clean criminal record and no driving convictions.

In addition to a six year jail-term, Aziz has been banned from driving for seven years.

MORE International ARTICLES

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic

Pfizer: Mid-November earliest it can seek virus vaccine OK

Pfizer: Mid-November earliest it can seek virus vaccine OK
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer: Mid-November earliest it can seek virus vaccine OK